Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism αvβ3 antagonists(Integrin alpha-V/beta-3 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H18N4O3 |
InChIKeyKTTBZGAYQRWZNQ-RQZCQDPDSA-N |
CAS Registry1477482-47-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Castration-Resistant Prostatic Cancer | Preclinical | CN | 10 Feb 2023 |